Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
ACS Chemical Biology|July 5, 2023
Robust Chemoenzymatic Synthesis of Keratinimicin Aglycone Analogues Facilitated by the Structure and Selectivity of OxyBNicole Hauser, Kendra A Ireland, Vasiliki T Chioti, et al.FEMS Yeast Research|October 18, 2006
An in vitro assay to study the transcriptional response during adherence of Candida albicans to different human epitheliaKai Sohn, Ilknur Senyürek, Jasmin Fertey, et al.Hispanic Health Care International : the Official Journal of the National Association of Hispanic Nurses|December 19, 2014
Cardiac genetic testing: a single-center pilot study of a Dominican populationKathleen T Hickey, Jacquelyn Y Taylor, Robert R Sciacca, et al.Neuropharmacology|December 6, 2011
Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophreniaDaniela Alberati, Jean-Luc Moreau, Judith Lengyel, et al.ACS Medicinal Chemistry Letters|June 6, 2014
3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 InhibitorsEmmanuel Pinard, Daniela Alberati, Ruben Alvarez-Sanchez, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2010
Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitorsEmmanuel Pinard, Daniela Alberati, Markus Bender, et al.Journal of Medicinal Chemistry|May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophreniaEmmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.Pageof 2